Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ECCO 2017 | Managing toxicity from immunotherapy

Martin Gore • 27 Jan 2017

Martin Gore, PhD, FRCP, CBE from the Royal Marsden NHS Foundation, London, UK discusses the risks from immunotherapy at the European Cancer Congress of the European Cancer Organisation (ECCO) 2017 in Amsterdam, Netherlands. Toxicity from immunotherapy is a significant consideration as they can lead to complex consequences, in particular, the combination of immune checkpoint inhibitors and CAR T-cells. Toxicity management is therefore something that needs to become more organised and managed.